Madrigal Pharmaceuticals (MDGL) insider files Form 144 for 2,500-share sale

Rhea-AI Filing Summary

Madrigal Pharmaceuticals, Inc. filed a notice of proposed sale of common stock under Form 144. The filing covers 2,500 shares of common stock held through Morgan Stanley Smith Barney LLC, with a proposed sale date of July 20, 2026 on the Nasdaq Stock Market. These shares were acquired upon the vesting of Performance Restricted Stock Units on July 17, 2026.

Key Figures

Shares proposed for sale: 2,500 shares Proposed sale date: 07/20/2026 Acquisition date: 07/17/2026 +1 more

4 metrics

Shares proposed for sale 2,500 shares Common stock under Form 144

Proposed sale date 07/20/2026 Listed as the date for potential sale of shares

Acquisition date 07/17/2026 Vesting of Performance Restricted Stock Units

Broker Morgan Stanley Smith Barney LLC Executive Financial Services listed for the transaction

Key Terms

Form 144, Performance Restricted Stock Unit Grant, vesting of Performance Restricted Stock Units

3 terms

Form 144 regulatory

"filed a notice of proposed sale of common stock under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Restricted Stock Unit Grant financial

"Performance Restricted Stock Unit Grant | Issuer | | | 2500"

vesting of Performance Restricted Stock Units financial

"Vesting of Performance Restricted Stock Units"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/20/2026 - 09:11 PM Accepted by SEC EDGAR 07/20/2026 - 09:11 PM Learn about SEC filing dates

FAQ

What does Madrigal Pharmaceuticals (MDGL) report in this Form 144?

Madrigal Pharmaceuticals reports a proposed sale of 2,500 shares of common stock under Form 144. The shares are to be sold on the Nasdaq Stock Market, with Morgan Stanley Smith Barney LLC as the broker.

How many MDGL shares are proposed to be sold and through which broker?

The filing covers 2,500 shares of Madrigal Pharmaceuticals common stock. The shares are held and proposed to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services in New York.

When are the MDGL shares expected to be sold according to the Form 144?

The Form 144 lists a proposed sale date of July 20, 2026. This is the date associated with the potential disposition of the 2,500 common shares on the Nasdaq Stock Market.

How were the 2,500 MDGL shares acquired before this proposed sale?

The 2,500 shares were acquired through a Performance Restricted Stock Unit Grant. The filing states the shares came from the vesting of Performance Restricted Stock Units on July 17, 2026 from the issuer.

What security is covered in the MDGL Form 144 filing?

The security covered is common stock of Madrigal Pharmaceuticals, Inc. The filing specifies 2,500 common shares proposed for sale on the Nasdaq Stock Market following the vesting of performance-based restricted stock units.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	2500	1383700	23055659	07/20/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/17/2026	Performance Restricted Stock Unit Grant	Issuer			2500	07/17/2026	Vesting of Performance Restricted Stock Units

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)